VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
IBRX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
IBRXImmunityBio, Inc.
$8.91$9.3B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksIBRXQuarterly Cash Flow

ImmunityBio, Inc. (IBRX) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

ImmunityBio, Inc. (IBRX) quarterly cash flow statement — complete operating, investing & financing history

IBRX Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Cash from Operations-75.36M-70.38M-68.91M-79.75M-85.91M-85.14M-98.76M-100.35M-106.98M-115.27M-87.4M-79.77M-84.31M-90.73M-80.6M-91.25M-74.93M-71.64M-72.72M-69.59M
Operating CF Margin %-170.47%-183.83%-214.92%-301.78%-520.1%-1127.44%-1617.47%-9584.24%-267455%-82928.78%-106589.02%-194568.29%-23419.44%-124283.56%-68305.08%-260720%-535214.29%-18368.97%-110175.76%-20529.5%
Operating CF Growth %12.28%17.34%30.23%20.53%19.7%26.14%-13%-25.79%-26.89%-27.05%-8.44%12.58%-12.52%-26.64%-10.84%-31.12%-23.91%-24.36%-96.58%-51.22%
Net Income-632.78M0-67.25M-92.56M-129.67M-59.18M-85.75M-134.58M-134.13M-233.41M-95.58M-138.21M-116.58M-108.33M-110.94M-94.59M-102.83M-91.26M-88.43M-88.29M
Depreciation & Amortization4.38M003.88M3.83M4.14M4.44M4.41M4.55M4.56M16.04M4.68M4.68M5.23M9M4.82M4.46M3.66M3.69M3.98M
Stock-Based Compensation0009.65M9.54M9.04M7.49M9.64M8.27M12.77M14.45M11.06M10.88M9.35M10.63M10.18M10.02M10.18M13.84M17.86M
Deferred Taxes0000000000000-4K000000
Other Non-Cash Items553.54M-55.97M-1.65M4.83M52.43M-28.3M-14.89M14.83M18.22M126.55M-18.04M33.64M-10.96M9.62M4.36M12.49M4.59M9.02M10.11M-1.17M
Working Capital Changes-500K-14.41M0-5.55M-22.04M-10.84M-10.05M5.36M-3.89M-25.75M-4.27M9.06M27.67M-6.59M6.35M-24.14M8.82M-3.24M-11.93M-1.99M
Change in Receivables-700K-10.55M0-5.1M-14.67M1.81M-3.14M0000000000000
Change in Inventory-4.99M-7.89M01.8M-172K-6.31M-147K0000000000000
Change in Payables3.9M979K0-6.22M6.44M-3.21M-8.92M4.66M4.31M-2.88M0-1.54M668K437K0000-2.77M0
Cash from Investing-31.65M43.57M-181.36M-16.14M4.13M9.83M65.03M-51.49M-35.62M2.25M-15.63M-8.6M-8.48M-18.89M-1.17M116.67M-69.31M-137.8M10.58M10.49M
Capital Expenditures-1.79M-1.27M0-1.08M-1.12M-2.11M-2.79M-724K-1.26M-7.96M-5.67M-8.53M-8.43M-18.93M-15.94M-15.95M-27.35M-10.4M-8.03M-8.04M
CapEx % of Revenue4.04%3.33%2.42%4.09%6.79%27.95%45.73%69.15%3152.5%5723.02%6920.73%20795.12%2341.11%25932.88%13504.24%45568.57%195335.71%2667.44%12169.7%2373.16%
Acquisitions00000000000056K1M000000
Investments--------------------
Other Investing00-181.36M000-1M000-9.96M0-56K-1M14.77M132.62M-41.97M-127.4M20.5M18.53M
Cash from Financing223.93M54.89M173.52M172.81M-982K106.93M15.58M148.89M10.22M200.54M237.5M43.41M76.89M109.94M123.99M-15K-298K325.95M42.66M98.34M
Debt Issued (Net)48K1.74M0-4K064K-22K-21K-21K-20K198.98M29.83M29.83M49.73M000298.5M00
Equity Issued (Net)231.74M53.74M0173.14M220K107.73M03.63M09.36M-1.46M13.51M47.29M60.43M-10K-15K-372K-480K41.92M0
Dividends Paid00000000000000000000
Share Repurchases0000000000-1.46M000-10K-15K-372K-480K00
Other Financing-7.86M-590K173.52M-322K-1.2M-867K15.6M145.29M10.25M191.2M39.98M75K-231K-219K124M074K27.93M734K98.34M
Net Change in Cash116.86M28.09M-76.81M77M-82.77M31.61M-18.14M-2.93M-132.42M87.49M134.47M-44.98M-16.16M480K42.26M25.66M-144.72M116.58M-19.43M39.28M
Free Cash Flow-77.15M-71.25M-69.68M-80.83M-87.03M-87.25M-101.56M-101.07M-108.24M-123.23M-93.08M-88.3M-92.74M-109.66M-96.53M-107.2M-102.28M-82.04M-80.75M-77.64M
FCF Margin %-174.51%-186.1%-217.34%-305.87%-526.89%-1155.39%-1663.2%-9653.39%-270607.5%-88651.8%-113509.76%-215363.41%-25760.56%-150216.44%-81809.32%-306288.57%-730550%-21036.41%-122345.45%-22902.65%
FCF Growth %11.35%18.35%31.39%20.03%19.6%29.19%-9.11%-14.46%-16.72%-12.37%3.58%17.63%9.33%-33.66%-19.55%-38.07%-51.4%-44.17%-106.86%-68.67%
FCF per Share-0.08-0.07-0.07-0.09-0.10-0.12-0.15-0.15-0.16-0.21-0.19-0.20-0.22-0.27-0.24-0.27-0.26-0.21-0.21-0.20
FCF Conversion (FCF/Net Income)0.12x1.14x1.02x0.86x0.66x1.44x1.15x0.75x0.80x0.49x0.91x0.58x0.72x0.84x0.73x0.96x0.73x0.79x0.83x0.79x
Interest Paid00018.86M020.87M23.56M23.98M23.91M44.29M7.38M10.01M014.44M9.85M6.11M5.04M640K624K830K
Taxes Paid00000-15K2K5K8K8K000-1K00001K0